+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Clinical Risk Grouping Solution Market - Global Forecast 2026-2032- Product Image
Clinical Risk Grouping Solution Market - Global Forecast 2026-2032- Product Image
Sale

Clinical Risk Grouping Solution Market - Global Forecast 2026-2032

  • Report

  • 187 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4995154
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Clinical Risk Grouping Solution Market is projected to reach USD 1.38 Billion in 2026. It is expected to continue growing at a CAGR of 14.72%, reaching USD 3.14 Billion by 2032.

Clinical risk grouping solutions are becoming core infrastructure for health plans, Medicare Advantage organizations, managed Medicaid programs, and commercial insurers seeking more accurate population health analytics, value-based reimbursement, and medical cost management. These platforms classify members into clinically meaningful cohorts based on diagnoses, utilization, demographics, pharmacy data, social risk indicators, and longitudinal care patterns, enabling payers to anticipate costs, identify avoidable utilization, and align interventions with patient complexity.

Demand is supported by verified healthcare fundamentals: health expenditure continues to account for a substantial share of GDP across advanced economies, chronic diseases remain the leading global causes of mortality and disability according to the World Health Organization, and value-based care programs increasingly require risk-adjusted performance measurement. For payers, clinical risk grouping improves actuarial accuracy, provider contract design, care management prioritization, quality measurement, and regulatory reporting while reducing reliance on fragmented claims-only analytics.

Transformative Shifts in the Payer Landscape

The payer landscape is shifting from retrospective cost review to predictive, member-centered risk intelligence. Traditional risk adjustment models remain important for reimbursement, but health plans now need more granular clinical risk stratification that supports proactive outreach, whole-person care, and equitable resource allocation. Interoperability rules, payer-to-payer data exchange, and growing adoption of FHIR-based health data standards are accelerating this transition.

Another transformative shift is the convergence of clinical, pharmacy, behavioral health, and social determinants of health data. Plans are using clinical risk grouping to identify high-risk members earlier, segment rising-risk populations, detect gaps in care, and improve quality outcomes. As government and employer purchasers demand measurable results, risk grouping is evolving from a finance function into a strategic operating layer for population health management, utilization oversight, and value-based care analytics.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is expanding the cumulative value of clinical risk grouping by improving prediction, pattern recognition, and intervention matching. Machine learning models can detect combinations of conditions, medication adherence patterns, emergency department use, prior admissions, and care gaps that precede avoidable hospitalizations. Natural language processing can add value when unstructured clinical notes are available through compliant data-sharing frameworks.

For payers, the opportunity is not only automation but better decision quality. AI-enabled risk grouping can enhance member segmentation, improve care manager caseload prioritization, support more timely provider collaboration, and strengthen population health management. However, model governance is essential. Plans must validate algorithms for bias, maintain explainability for clinical and regulatory users, and ensure compliance with HIPAA, CMS guidance, state privacy laws, GDPR where applicable, and emerging AI accountability frameworks.

Key Regional Insights

North America remains the most mature region for clinical risk grouping solutions because of high healthcare spending, established risk adjustment programs, widespread claims data infrastructure, and rapid growth in value-based care. The United States leads adoption through Medicare Advantage, Medicaid managed care, accountable care arrangements, and employer-sponsored health analytics, while Canada’s provincial health systems use risk stratification to support resource planning, chronic disease management, and quality improvement.

Europe shows strong demand for clinically governed, privacy-compliant risk grouping, shaped by national health systems, the General Data Protection Regulation, and the European Health Data Space agenda. Asia-Pacific is expanding as aging populations, universal coverage initiatives, and digital health investments in China, Japan, India, South Korea, Australia, and ASEAN markets increase the need for predictive population health tools. Latin America is adopting risk grouping through payer modernization and private-provider networks, led by Brazil and Mexico, while the Middle East is advancing through health system digitization, insurance reform, and payer-provider integration in GCC countries. Africa remains earlier-stage but increasingly relevant as governments and donors prioritize analytics for noncommunicable disease management, insurance expansion, and limited-resource allocation.

Key Group Insights

The G7 economies are influential for payer-focused clinical risk grouping because they combine high health expenditure, mature insurance or national health systems, advanced digital infrastructure, and policy attention to aging populations. Their emphasis on chronic disease prevention, quality measurement, and value-based reimbursement supports investment in predictive risk analytics. The European Union is important because GDPR-compliant data governance and cross-border health data initiatives are shaping standards for explainable, privacy-preserving risk grouping.

BRICS markets represent scale-driven opportunity, especially as China, India, and Brazil expand digital health platforms, insurance coverage, and chronic disease programs. ASEAN countries are progressing unevenly but show growing need for affordable population health analytics as universal coverage and health financing reforms advance. GCC governments are investing heavily in health transformation, electronic medical records, insurance modernization, and payer-provider integration, creating demand for enterprise risk stratification. NATO members overlap with many high-income digital health markets, where cybersecurity, resilience, and trusted data exchange are increasingly tied to healthcare analytics procurement.

Key Country Insights

The United States is the most commercially advanced country for payer clinical risk grouping, driven by Medicare Advantage risk adjustment, Medicaid managed care, commercial utilization management, and accountable care contracts. Canada uses risk grouping within provincial planning, quality improvement, and chronic disease strategies, while Mexico and Brazil show rising adoption through private insurers, integrated provider groups, and public health modernization.

In Europe, the United Kingdom, Germany, France, Italy, and Spain are advancing data-driven population health within national and regional care systems, with strong emphasis on privacy, transparency, and equitable access. Russia’s adoption is more influenced by centralized health infrastructure and domestic digital health priorities. China is scaling health data platforms and chronic disease management programs, India is building momentum through digital public infrastructure and insurance expansion, Japan’s super-aged population makes risk stratification essential, Australia emphasizes integrated care and rural access, and South Korea combines strong digital health capability with high demand for predictive chronic disease analytics.

Actionable Recommendations for Industry Leaders

Payer executives should prioritize clinical risk grouping as an enterprise capability rather than a standalone actuarial tool. The highest-value deployments connect risk scores to care management workflows, provider contracting, quality improvement, pharmacy programs, behavioral health navigation, utilization management, and member engagement.

Industry leaders should invest in interoperable data pipelines, clinically explainable models, transparent governance, and continuous validation against outcomes such as avoidable admissions, emergency department use, medication adherence, care gap closure, and total cost of care. Partnerships with providers are critical because the best risk grouping programs turn analytics into coordinated interventions, not just reports.

Research Methodology

This executive summary is based on secondary research, policy analysis, and triangulation of publicly available evidence from recognized sources, including the World Health Organization, OECD, CMS, national health ministries, peer-reviewed population health literature, interoperability standards bodies, and regulatory frameworks governing health data privacy and AI.

The analysis evaluates market drivers, regional adoption patterns, technology maturity, reimbursement models, data governance requirements, and operational use cases for clinical risk grouping solutions. Insights are synthesized for relevance across keywords such as clinical risk grouping, risk stratification, population health management, value-based care analytics, risk adjustment, healthcare predictive analytics, and payer analytics.

Conclusion

Clinical risk grouping solutions are becoming indispensable for payers navigating cost pressure, chronic disease burden, regulatory complexity, and the shift to value-based care. The strongest opportunities are emerging where claims, clinical, pharmacy, behavioral health, and social risk data can be combined into actionable intelligence.

For health plans, competitive advantage will depend on moving beyond retrospective risk adjustment toward AI-supported, clinically explainable, and workflow-integrated risk segmentation. Organizations that pair robust analytics with trusted provider collaboration will be best positioned to improve outcomes, manage costs, and deliver measurable value.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Clinical Risk Grouping Solution Market, by Component
7.1. Introduction
7.2. Software
7.2.1. Standalone
7.2.2. Integrated
7.2.3. Platform based
7.3. Services
7.3.1. Consulting
7.3.2. Training
7.3.3. Support & Maintenance
8. Clinical Risk Grouping Solution Market, by Deployment Mode
8.1. Introduction
8.2. Cloud Based
8.2.1. Hybrid Cloud
8.2.2. Private Cloud
8.2.3. Public Cloud
8.3. On Premise
9. Clinical Risk Grouping Solution Market, by Risk Type
9.1. Introduction
9.2. Clinical Risk
9.3. Financial Risk
9.4. Operational Risk
9.5. Population Risk
10. Clinical Risk Grouping Solution Market, by Technology
10.1. Introduction
10.2. Artificial Intelligence
10.3. Machine Learning
10.4. Natural Language Processing
10.5. Predictive Modeling
10.6. Cloud Computing
10.7. Interoperability Solutions
11. Clinical Risk Grouping Solution Market, by Organization Size
11.1. Introduction
11.2. Large Enterprises
11.3. Small & Medium Enterprises
12. Clinical Risk Grouping Solution Market, by Application
12.1. Introduction
12.2. Chronic Disease Management
12.2.1. Diabetes
12.2.2. Cardiovascular Diseases
12.2.3. Respiratory Diseases
12.3. Acute Care Risk Assessment
12.3.1. Emergency Triage
12.3.2. ICU Risk Scoring
12.4. Readmission Risk Analysis
12.5. Sepsis Prediction
12.6. Mortality Risk Prediction
13. Clinical Risk Grouping Solution Market, by End User
13.1. Introduction
13.2. Hospitals
13.3. Clinics
13.4. Ambulatory Care Centers
14. Clinical Risk Grouping Solution Market, by Region
14.1. Asia-Pacific
14.2. North America
14.3. Latin America
14.4. Europe
14.5. Middle East
14.6. Africa
15. Clinical Risk Grouping Solution Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Clinical Risk Grouping Solution Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. Competitive Landscape
17.1. Market Share Analysis, 2025
17.2. FPNV Positioning Matrix, 2025
17.3. Market Concentration Analysis, 2025
17.3.1. Concentration Ratio (CR)
17.3.2. Herfindahl Hirschman Index (HHI)
17.4. Recent Developments & Impact Analysis, 2025
17.5. Product Portfolio Analysis, 2025
17.6. Benchmarking Analysis, 2025
18. Company Profiles
18.1. 3M Company
18.2. Change Healthcare Inc
18.3. CodaMetrix Inc
18.4. Conduent Inc
18.5. Cotiviti Inc
18.6. Edifecs Inc
18.7. Epic Systems Corporation
18.8. Evolent Health Inc
18.9. HBI Solutions Inc
18.10. Health Catalyst Inc
18.11. Health Fidelity Inc
18.12. Inovalon Holdings Inc
18.13. IQVIA Holdings Inc
18.14. Johns Hopkins University
18.15. Lightbeam Health Solutions Inc
18.16. Med-IQ Inc
18.17. Microsoft Corporation
18.18. Milliman Inc
18.19. Optum Inc
18.20. Oracle Corporation
18.21. Persivia Inc
18.22. Reveleer Inc
18.23. Solventum Corporation
18.24. Veradigm Inc
List of Figures
FIGURE 1. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COMPONENT, 2025 VS 2032 (%)
FIGURE 7. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY RISK TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY RISK TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 13. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 19. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 23. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 25. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 27. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL STANDALONE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL STANDALONE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL STANDALONE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL INTEGRATED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL INTEGRATED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL INTEGRATED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL PLATFORM BASED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL PLATFORM BASED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL PLATFORM BASED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL CONSULTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL CONSULTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL CONSULTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL TRAINING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL TRAINING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL TRAINING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL SUPPORT & MAINTENANCE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL SUPPORT & MAINTENANCE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL SUPPORT & MAINTENANCE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL CLOUD BASED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL CLOUD BASED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL CLOUD BASED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL HYBRID CLOUD MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL HYBRID CLOUD MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL HYBRID CLOUD MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL PRIVATE CLOUD MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL PRIVATE CLOUD MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL PRIVATE CLOUD MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL PUBLIC CLOUD MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL PUBLIC CLOUD MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL PUBLIC CLOUD MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL ON PREMISE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL ON PREMISE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL ON PREMISE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY RISK TYPE, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL CLINICAL RISK MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL CLINICAL RISK MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL CLINICAL RISK MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL FINANCIAL RISK MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL FINANCIAL RISK MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL FINANCIAL RISK MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL OPERATIONAL RISK MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL OPERATIONAL RISK MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL OPERATIONAL RISK MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL POPULATION RISK MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL POPULATION RISK MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL POPULATION RISK MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL ARTIFICIAL INTELLIGENCE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL ARTIFICIAL INTELLIGENCE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL ARTIFICIAL INTELLIGENCE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL MACHINE LEARNING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL MACHINE LEARNING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL MACHINE LEARNING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL NATURAL LANGUAGE PROCESSING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL NATURAL LANGUAGE PROCESSING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL NATURAL LANGUAGE PROCESSING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL PREDICTIVE MODELING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL PREDICTIVE MODELING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL PREDICTIVE MODELING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL CLOUD COMPUTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL CLOUD COMPUTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL CLOUD COMPUTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL INTEROPERABILITY SOLUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL INTEROPERABILITY SOLUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL INTEROPERABILITY SOLUTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL LARGE ENTERPRISES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL LARGE ENTERPRISES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL LARGE ENTERPRISES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL SMALL & MEDIUM ENTERPRISES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL SMALL & MEDIUM ENTERPRISES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL SMALL & MEDIUM ENTERPRISES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL DIABETES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL DIABETES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL DIABETES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL RESPIRATORY DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL RESPIRATORY DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL RESPIRATORY DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL ACUTE CARE RISK ASSESSMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL ACUTE CARE RISK ASSESSMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL ACUTE CARE RISK ASSESSMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL EMERGENCY TRIAGE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL EMERGENCY TRIAGE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL EMERGENCY TRIAGE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL ICU RISK SCORING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL ICU RISK SCORING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL ICU RISK SCORING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL READMISSION RISK ANALYSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL READMISSION RISK ANALYSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL READMISSION RISK ANALYSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL SEPSIS PREDICTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL SEPSIS PREDICTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL SEPSIS PREDICTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL MORTALITY RISK PREDICTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL MORTALITY RISK PREDICTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL MORTALITY RISK PREDICTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 126. ASIA-PACIFIC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 128. ASIA-PACIFIC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CLOUD BASED, 2017-2032 (USD MILLION)
TABLE 131. ASIA-PACIFIC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY RISK TYPE, 2017-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2017-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 136. ASIA-PACIFIC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ACUTE CARE RISK ASSESSMENT, 2017-2032 (USD MILLION)
TABLE 137. ASIA-PACIFIC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 138. NORTH AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 139. NORTH AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 140. NORTH AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 141. NORTH AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 142. NORTH AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 143. NORTH AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CLOUD BASED, 2017-2032 (USD MILLION)
TABLE 144. NORTH AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY RISK TYPE, 2017-2032 (USD MILLION)
TABLE 145. NORTH AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 146. NORTH AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2017-2032 (USD MILLION)
TABLE 147. NORTH AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 148. NORTH AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 149. NORTH AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ACUTE CARE RISK ASSESSMENT, 2017-2032 (USD MILLION)
TABLE 150. NORTH AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 151. LATIN AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 152. LATIN AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 153. LATIN AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 154. LATIN AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 155. LATIN AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 156. LATIN AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CLOUD BASED, 2017-2032 (USD MILLION)
TABLE 157. LATIN AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY RISK TYPE, 2017-2032 (USD MILLION)
TABLE 158. LATIN AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 159. LATIN AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2017-2032 (USD MILLION)
TABLE 160. LATIN AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 161. LATIN AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 162. LATIN AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ACUTE CARE RISK ASSESSMENT, 2017-2032 (USD MILLION)
TABLE 163. LATIN AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 164. EUROPE CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 165. EUROPE CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 166. EUROPE CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 167. EUROPE CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 168. EUROPE CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 169. EUROPE CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CLOUD BASED, 2017-2032 (USD MILLION)
TABLE 170. EUROPE CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY RISK TYPE, 2017-2032 (USD MILLION)
TABLE 171. EUROPE CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 172. EUROPE CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2017-2032 (USD MILLION)
TABLE 173. EUROPE CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 174. EUROPE CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 175. EUROPE CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ACUTE CARE RISK ASSESSMENT, 2017-2032 (USD MILLION)
TABLE 176. EUROPE CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 177. MIDDLE EAST CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 178. MIDDLE EAST CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 179. MIDDLE EAST CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 180. MIDDLE EAST CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 181. MIDDLE EAST CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 182. MIDDLE EAST CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CLOUD BASED, 2017-2032 (USD MILLION)
TABLE 183. MIDDLE EAST CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY RISK TYPE, 2017-2032 (USD MILLION)
TABLE 184. MIDDLE EAST CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 185. MIDDLE EAST CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2017-2032 (USD MILLION)
TABLE 186. MIDDLE EAST CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 187. MIDDLE EAST CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 188. MIDDLE EAST CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ACUTE CARE RISK ASSESSMENT, 2017-2032 (USD MILLION)
TABLE 189. MIDDLE EAST CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 190. AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 191. AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 192. AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 193. AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 194. AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 195. AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CLOUD BASED, 2017-2032 (USD MILLION)
TABLE 196. AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY RISK TYPE, 2017-2032 (USD MILLION)
TABLE 197. AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 198. AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2017-2032 (USD MILLION)
TABLE 199. AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 200. AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 201. AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ACUTE CARE RISK ASSESSMENT, 2017-2032 (USD MILLION)
TABLE 202. AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 203. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 204. ASEAN CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 205. ASEAN CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 206. ASEAN CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 207. ASEAN CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 208. ASEAN CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 209. ASEAN CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CLOUD BASED, 2017-2032 (USD MILLION)
TABLE 210. ASEAN CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY RISK TYPE, 2017-2032 (USD MILLION)
TABLE 211. ASEAN CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 212. ASEAN CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2017-2032 (USD MILLION)
TABLE 213. ASEAN CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 214. ASEAN CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 215. ASEAN CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ACUTE CARE RISK ASSESSMENT, 2017-2032 (USD MILLION)
TABLE 216. ASEAN CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 217. GCC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 218. GCC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 219. GCC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 220. GCC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 221. GCC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 222. GCC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CLOUD BASED, 2017-2032 (USD MILLION)
TABLE 223. GCC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY RISK TYPE, 2017-2032 (USD MILLION)
TABLE 224. GCC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 225. GCC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2017-2032 (USD MILLION)
TABLE 226. GCC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 227. GCC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 228. GCC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ACUTE CARE RISK ASSESSMENT, 2017-2032 (USD MILLION)
TABLE 229. GCC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 234. EUROPEAN UNION CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 235. EUROPEAN UNION CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CLOUD BASED, 2017-2032 (USD MILLION)
TABLE 236. EUROPEAN UNION CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY RISK TYPE, 2017-2032 (USD MILLION)
TABLE 237. EUROPEAN UNION CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 238. EUROPEAN UNION CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2017-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 241. EUROPEAN UNION CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ACUTE CARE RISK ASSESSMENT, 2017-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 243. BRICS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 244. BRICS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 245. BRICS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 246. BRICS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 247. BRICS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 248. BRICS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CLOUD BASED, 2017-2032 (USD MILLION)
TABLE 249. BRICS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY RISK TYPE, 2017-2032 (USD MILLION)
TABLE 250. BRICS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 251. BRICS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2017-2032 (USD MILLION)
TABLE 252. BRICS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 253. BRICS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 254. BRICS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ACUTE CARE RISK ASSESSMENT, 2017-2032 (USD MILLION)
TABLE 255. BRICS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 256. G7 CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 257. G7 CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 258. G7 CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 259. G7 CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 260. G7 CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 261. G7 CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CLOUD BASED, 2017-2032 (USD MILLION)
TABLE 262. G7 CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY RISK TYPE, 2017-2032 (USD MILLION)
TABLE 263. G7 CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 264. G7 CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2017-2032 (USD MILLION)
TABLE 265. G7 CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 266. G7 CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 267. G7 CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ACUTE CARE RISK ASSESSMENT, 2017-2032 (USD MILLION)
TABLE 268. G7 CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 269. NATO CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 270. NATO CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 271. NATO CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 272. NATO CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 273. NATO CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 274. NATO CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CLOUD BASED, 2017-2032 (USD MILLION)
TABLE 275. NATO CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY RISK TYPE, 2017-2032 (USD MILLION)
TABLE 276. NATO CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 277. NATO CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2017-2032 (USD MILLION)
TABLE 278. NATO CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 279. NATO CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 280. NATO CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ACUTE CARE RISK ASSESSMENT, 2017-2032 (USD MILLION)
TABLE 281. NATO CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 282. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 283. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 284. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 285. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 286. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 287. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 288. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CLOUD BASED, 2017-2032 (USD MILLION)
TABLE 289. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY RISK TYPE, 2017-2032 (USD MILLION)
TABLE 290. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 291. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2017-2032 (USD MILLION)
TABLE 292. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 293. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 294. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ACUTE CARE RISK ASSESSMENT, 2017-2032 (USD MILLION)
TABLE 295. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 296. CANADA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 297. CANADA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 298. CANADA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 299. CANADA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 300. CANADA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 301. CANADA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CLOUD BASED, 2017-2032 (USD MILLION)
TABLE 302. CANADA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY RISK TYPE, 2017-2032 (USD MILLION)
TABLE 303. CANADA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 304. CANADA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2017-2032 (USD MILLION)
TABLE 305. CANADA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 306. CANADA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 307. CANADA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ACUTE CARE RISK ASSESSMENT, 2017-2032 (USD MILLION)
TABLE 308. CANADA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 309. MEXICO CLINICAL RISK GROUPING SOLUTION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 310. MEXICO CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 311. MEXICO CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 312. MEXICO CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 313. MEXICO CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 314. MEXICO CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CLOUD BASED, 2017-2032 (USD MILLION)
TABLE 315. MEXICO CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY RISK TYPE, 2017-2032 (USD MILLION)
TABLE 316. MEXICO CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 317. MEXICO CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2017-2032 (USD MILLION)
TABLE 318. MEXICO CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 319. MEXICO CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 320. MEXICO CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ACUTE CARE RISK ASSESSMENT, 2017-2032 (USD MILLION)
TABLE 321. MEXICO CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 322. BRAZIL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 323. BRAZIL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 324. BRAZIL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 325. BRAZIL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 326. BRAZIL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 327. BRAZIL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CLOUD BASED, 2017-2032 (USD MILLION)
TABLE 328. BRAZIL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY RISK TYPE, 2017-2032 (USD MILLION)
TABLE 329. BRAZIL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 330. BRAZIL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2017-2032 (USD MILLION)
TABLE 331. BRAZIL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 332. BRAZIL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 333. BRAZIL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ACUTE CARE RISK ASSESSMENT, 2017-2032 (USD MILLION)
TABLE 334. BRAZIL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 335. UNITED KINGDOM CLINICAL RISK GROUPING SOLUTION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 336. UNITED KINGD

Companies Mentioned

  • 3M Company
  • Change Healthcare Inc
  • CodaMetrix Inc
  • Conduent Inc
  • Cotiviti Inc
  • Edifecs Inc
  • Epic Systems Corporation
  • Evolent Health Inc
  • HBI Solutions Inc
  • Health Catalyst Inc
  • Health Fidelity Inc
  • Inovalon Holdings Inc
  • IQVIA Holdings Inc
  • Johns Hopkins University
  • Lightbeam Health Solutions Inc
  • Med-IQ Inc
  • Microsoft Corporation
  • Milliman Inc
  • Optum Inc
  • Oracle Corporation
  • Persivia Inc
  • Reveleer Inc
  • Solventum Corporation
  • Veradigm Inc

Table Information

Report AttributeDetails
No. of Pages187
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.38 Billion
Forecasted Market Value ( USD ) by 2032 $ 3.14 Billion
Compound Annual Growth Rate14.7%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Clinical Risk Grouping Solutions - Global Strategic Business Report - Product Image

Clinical Risk Grouping Solutions - Global Strategic Business Report

  • Report
  • 367 Pages
  • Global
From
Clinical Risk Grouping Solution Market Report 2026 - Product Image

Clinical Risk Grouping Solution Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Clinical Risk Grouping Solutions Market Outlook 2026-2034: Market Share, and Growth Analysis by Deployment, Product, End User - Product Image

Clinical Risk Grouping Solutions Market Outlook 2026-2034: Market Share, and Growth Analysis by Deployment, Product, End User

  • Report
  • 160 Pages
  • Global
From
Healthcare Predictive Analytics Market - Global Forecast 2026-2032 - Product Image

Healthcare Predictive Analytics Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Healthcare Business Intelligence Market - Global Forecast 2026-2032 - Product Image

Healthcare Business Intelligence Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From

About the Clinical Risk Grouping Solutions Market

Clinical Risk Grouping Solutions (CRGS) are a type of healthcare analytics that allow healthcare providers to identify and manage risk factors associated with patient care. CRGS use predictive analytics to identify and stratify patients into risk groups based on their medical history, demographics, and other factors. This allows healthcare providers to better understand the risk of a patient developing a certain condition or requiring a certain type of care. CRGS also allow healthcare providers to identify and target high-risk patients for preventive care and interventions. CRGS are used in a variety of healthcare settings, including hospitals, clinics, and long-term care facilities. They are also used to inform healthcare policy decisions, such as the allocation of resources and the development of clinical guidelines. Some companies in the Clinical Risk Grouping Solutions market include Optum, Cerner, IBM Watson Health, and Allscripts. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.